Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 4,814 shares at $76.43 ($368K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Open-market sale of $368k TMDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.43 | 2,407 | $184K | 50.0% |
| 2 | $76.43 | 2,407 | $184K | 50.0% |
| Total | $76.43 avg | 4,814 | $368K | 100% |
| Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |
| TMDX | SELL | 2024-10-03 | $637K | — | Filing → |